According to the research report titled, “United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 - 2020 and Industry Forecast 2021 - 2027”, available with MarketStudyReport, United States self-monitoring blood glucose market is expected to surpass USD 4.6 billion by the end of forecast period 2021-2027.
 

Increasing diabetic population is primarily driving United States self-monitoring blood glucose (SMBG) market growth. Benefits such as economical, accurate, portable with frequent use-case as compared to one-time use of glucometers are accelerating the adoption of MSBG products.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3140355/
 

Moreover, technological advancements in concerned devices have boosted patient knowledge for use at home. High investments in R&D is projected to further augment the market growth during forecast period, claims the study.
 

For the uninitiated, SMBG is an approach wherein a diabetic patient uses a glycemic reader to assess blood sugar levels. A patient checking effectiveness of their treatment (diet, exercise, insulin, antidiabetics and stress management) based on this reading.
 

Notably, Type 1 diabetes population in United States is predicted to expand coming years, making it essential for patients to continue monitoring blood glucose levels as low levels result in diabetic retinopathy, diabetic neuropathy, and other complications.
 

The self-monitoring blood glucose industry in United States is also studied from the perspective of blood glucose meter users volume, blood glucose test strips users volume, and blood glucose lancet users volume to provide a holistic understanding of the size and scope of this domain. Besides this, reimbursement scenario and regulatory framework data concerning blood monitoring devices are covered in the document.
 

As per the competitive landscape analysis, Roche, LifeScan, Inc., Arkray, Inc., ForaCare, Inc., Waveform Diabetes (Formerly AgaMatrix Holdings, LLC), Fifty50 Medical LLC, iHealth Labs Inc., Oak Tree Health, Livongo Health Inc., ., Simple Diagnostics Inc., Dario Health Corp., One Drop Inc., Osang Healthcare Co., Sanofi Corp, Walgreens, i-SENS, Inc., and Medtronic plc are among the leading companies in United States self-monitoring blood glucose market. Recent mergers and acquisitions that occurred between some of the aforementioned companies have helped them strengthen their market presence. Besides, new product development and launches, and R&D investments are expected present new business opportunities for industry players.